Studies have reported an increased prevalence of MetS, dyslipidemia, and PCOS and higher levels of fasting plasma glucose, insulin, and tryglycerides in patients suffering from HS, while obesity is recognized as an exacerbating factor [67,68,69]. This evidence concerns the gene INS and metabolic syndrome.